Ocular effects of selective alpha-adrenergic agents: a new drug paradox?
Mittag, T.
Annals of Ophthalmology 15(3): 201-202
1983
ISSN/ISBN: 0003-4886 PMID: 6133494 Document Number: 212649
Alpha-adrenergic drugs can alter pupil size as well as intraocular pressure (IOP) when administered topically to the eye. Recent experiments using the more selective alpha-adrenergic agents suggest that these responses may be mediated by at least three subtypes of alpha-adrenergic receptors. These studies have also given rise to an apparent paradox because both agonists and antagonists cause a lowering in IOP.
Document emailed within 1 workday
Related Documents
Apponi-Battini, G.; Barra, A.; De Simone, C.; Rossi, F.; Berrino, L.; Cazzola, M.; Marmo, E. 1984: Systemic and ocular effects of alpha 2-adrenergic stimulating and beta 2-blocking agents Journal of Medicine 15(2): 126-134Uhlén, S.; Porter, A.C.; Neubig, R.R. 1994: The novel alpha-2 adrenergic radioligand [3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors Journal of Pharmacology and Experimental Therapeutics 271(3): 1558-1565
Allen, G.S.; Gross, C.J. 1976: Cerebral arterial spasm. Part 7: in vitro effects of alpha adrenergic agents on canine arteries from six anatomical sites and six blocking agents on serotonin-induced contractions of the canine basilar artery Surgical Neurology 6(2): 63-70
Renouard, A.; Widdowson, P.S.; Millan, M.J. 1994: Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes Journal of Pharmacology and Experimental Therapeutics 270(3): 946-957
Holland, M.G. 1974: Autonomic drugs in ophthalmology: Some problems and promises. Section IV: Sympatholytic and sympathetic blocking agents--alpha adrenergic antagonists and beta adrenergic antagonists Annals of Ophthalmology 6(11): 1139-1142
Bylund, D.B.; Iversen, L.J.; Matulka, W.J.; Chacko, D.M. 1997: Characterization of alpha-2D adrenergic receptor subtypes in bovine ocular tissue homogenates Journal of Pharmacology and Experimental Therapeutics 281(3): 1171-1177
Limon, L. 1990: The use of alpha 1 adrenergic blocking agents for hypertension American Pharmacy 30(6): 54-58
Huidobro-Toro, J.P.; Carpi, A. 1976: Selective blocking properties of chloro acetyl catechol (CAC) on the alpha-adrenergic receptor Archives Internationales de Pharmacodynamie et de Therapie 222(2): 180-192
Perrigot, M.; Vannier, A.; Bor, Y. 1986: Alpha adrenergic blocking agents in disorders of the bladder sphincter La Revue du Praticien 36(5): 223-228
Nebigil, C.; Malik, K.U. 1992: Prostaglandin synthesis elicited by adrenergic stimuli is mediated via alpha-2C and alpha-1A adrenergic receptors in cultured smooth muscle cells of rabbit aorta Journal of Pharmacology and Experimental Therapeutics 260(2): 849-858
Zebrowska-Lupina, I. 1978: Studies on the mechanisms of central action of alpha-adrenergic receptor blocking agents Polish Journal of Pharmacology and Pharmacy 30(4): 455-458
Skuza, G.; Kolasiewicz, W. 2001: Repeated treatment with SA4503, a selective sigma1 receptor agonist, up-regulates alpha-adrenergic system. a behavioral study Polish Journal of Pharmacology 53(5): 547-550
Jakobs, K.H. 1978: Synthetic alpha-adrenergic agonists are potent alpha-adrenergic blockers in human platelets Nature 274(5673): 819-820
Mukherjee, K.C.; Sur, R.N.; Kar, K.; Dhawan, B.N. 1972: Effect of alpha adrenergic blocking agents on myocardial toxicity of cardiac glycosides in guinea-pigs Indian Journal of Experimental Biology 10(1): 16-19
McKernan, R.M.; Strickland, W.R.; Insel, P.A. 1988: Selective blockade and recovery of cell surface alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Studies with the irreversible antagonist benextramine Molecular Pharmacology 33(1): 51-57
Price, D.T.; Lefkowitz, R.J.; Caron, M.G.; Berkowitz, D.; Schwinn, D.A. 1994: Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology Molecular Pharmacology 45(2): 171-175
Ehongo, A.; Bremer, F. 2007: Ocular side effects of glaucoma treatment agents Bulletin de la Societe Belge d'Ophtalmologie 304: 103-110
Gendenshteĭn, E.I.; Volkova, N.D. 1974: Effect of adrenergic and antiadrenergic agents on the toxic effects of strophanthin Farmakologiia i Toksikologiia 37(6): 727-729
Boksay, I.; Bollmann, V.; Popendiker, K. 1971: Influence of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine on alpha-adrenergic effects Arzneimittel-Forschung 21(8): 1174-1177
Valencia, I.; Castillo, C.; Hong, E. 1991: Contractile and relaxant effects of alpha-adrenergic agonists on rat aorta Proceedings of the Western Pharmacology Society 34: 149-151